mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria.
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
10 Jan 2024
10 Jan 2024
Historique:
medline:
10
1
2024
pubmed:
10
1
2024
entrez:
10
1
2024
Statut:
ppublish
Résumé
The urea cycle enzyme argininosuccinate lyase (ASL) enables the clearance of neurotoxic ammonia and the biosynthesis of arginine. Patients with ASL deficiency present with argininosuccinic aciduria, an inherited metabolic disease with hyperammonemia and a systemic phenotype coinciding with neurocognitive impairment and chronic liver disease. Here, we describe the dysregulation of glutathione biosynthesis and upstream cysteine utilization in ASL-deficient patients and mice using targeted metabolomics and in vivo positron emission tomography (PET) imaging using (
Identifiants
pubmed: 38198573
doi: 10.1126/scitranslmed.adh1334
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM